Stocks / NASDAQ / Inozyme Pharma Inc.

Inozyme Pharma Inc.

Our Opinion

Inozyme Pharma Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“In ABCC6-deficient mouse models, dosing with INZ-701 also increased plasma PPi levels. In addition to normalizing levels of PPi, in preclinical studies, INZ-701 prevented neointimal proliferation in both wild-type and ENPP1-deficient mice. The nonclinical INZ-701 toxicology studies that Inozyme has conducted in two animal species showed no systemic adverse effects at doses that significantly exceeded potential human doses.” Read the following article

Company Description

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.

Company Website: